COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices)


Summary

Integra Lifesciences Holding Corp. (Integra),is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, headquartered in United States of America with global manufacturing and sales reach. Integra Lifesciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel?, Bactiseal?, Cadence?, CertasTM, Codman?, CUSA?, DuraGen?, DuraSeal? and many more. Company’s presence is seen in Wound care management, neurological devices, general surgery, orthopedic and dental devices. The report, COVID-19 Impact on Integra Lifesciences Holdings Corp.’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Integra Lifesciences Holdings Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Integra Lifesciences Holdings Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.


Key Highlights

  • The spread of the disease in recent days has put a much large proportion of Integra Lifesciences Holdings Corp’s at risk.
  • In particular the heavy impact in Europe and rapid rise of COVID-19 cases in the US mean that the general outlook for sales has significantly declined in the past week.
  • The company may experience a short term up tick in critical care devices, but will be impacted harshly due to presence in products related to elective procedures.




Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Integra Lifesciences Holdings Corp. -

  • It provides insights on Integra Lifesciences Holdings Corp.’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
  • It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.




Reasons To Buy

  • An overview of how Integra Lifesciences Holdings Corp. will be affected by the COVID-19 pandemic.